Literature DB >> 11893070

The biosynthesis of acarbose and validamycin.

T Mahmud1, S Lee, H G Floss.   

Abstract

The studies reported here have established the biosynthetic origin of the mC7N units of acarbose and validamycin from sedo-heptulose 7-phosphate, and have identified 2-epi-5-epi-valiolone as the initial cyclization product. The deoxyhexose moiety of acarbose arises from glucose with deoxythymidyl-diphospho-4-keto-6-deoxy-D-glucose (dTDP-4-keto-6-deoxy-D-glucose) as a proximate intermediate. However, despite the identical origin of the aminocyclitol moieties in acarbose and validamycin A, the pathways of their formation seem to be substantially different. Validamycin A formation involves a number of discrete ketocyclitol intermediates, 5-epi-valiolone, valienone, and validone, whereas no free intermediates have been identified on the pathway from 2-epi-5-epi-valiolone to the pseudodisaccharide moiety of acarbose. The stage is now set for unraveling the mechanism or mechanisms by which the two components of the pseudodisaccharide moieties of acarbose and validamycin are uniquely coupled to each other via a nitrogen bridge.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11893070     DOI: 10.1002/tcr.1015

Source DB:  PubMed          Journal:  Chem Rec        ISSN: 1528-0691            Impact factor:   6.771


  9 in total

1.  Functional analysis of the validamycin biosynthetic gene cluster and engineered production of validoxylamine A.

Authors:  Linquan Bai; Lei Li; Hui Xu; Kazuyuki Minagawa; Yi Yu; Yirong Zhang; Xiufen Zhou; Heinz G Floss; Taifo Mahmud; Zixin Deng
Journal:  Chem Biol       Date:  2006-04

2.  Nucleotidylation of unsaturated carbasugar in validamycin biosynthesis.

Authors:  Jongtae Yang; Hui Xu; Yirong Zhang; Linquan Bai; Zixin Deng; Taifo Mahmud
Journal:  Org Biomol Chem       Date:  2010-10-27       Impact factor: 3.876

3.  A novel osmolality-shift fermentation strategy for improving acarbose production and concurrently reducing byproduct component C formation by Actinoplanes sp. A56.

Authors:  Xin Cheng; Wei-Fu Peng; Lin Huang; Bao Zhang; Kun-Tai Li
Journal:  J Ind Microbiol Biotechnol       Date:  2014-10-09       Impact factor: 3.346

4.  ValC, a new type of C7-Cyclitol kinase involved in the biosynthesis of the antifungal agent validamycin A.

Authors:  Kazuyuki Minagawa; Yirong Zhang; Takuya Ito; Linquan Bai; Zixin Deng; Taifo Mahmud
Journal:  Chembiochem       Date:  2007-04-16       Impact factor: 3.164

5.  Complete biosynthetic pathway to the antidiabetic drug acarbose.

Authors:  Takeshi Tsunoda; Arash Samadi; Sachin Burade; Taifo Mahmud
Journal:  Nat Commun       Date:  2022-06-15       Impact factor: 17.694

6.  Genetically engineered production of 1,1'-bis-valienamine and validienamycin in Streptomyces hygroscopicus and their conversion to valienamine.

Authors:  Hui Xu; Jongtae Yang; Linquan Bai; Zixin Deng; Taifo Mahmud
Journal:  Appl Microbiol Biotechnol       Date:  2008-09-27       Impact factor: 4.813

7.  Biosynthetic gene cluster of cetoniacytone A, an unusual aminocyclitol from the endosymbiotic Bacterium Actinomyces sp. Lu 9419.

Authors:  Xiumei Wu; Patricia M Flatt; Hui Xu; Taifo Mahmud
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

8.  Genomic and transcriptomic insights into the thermo-regulated biosynthesis of validamycin in Streptomyces hygroscopicus 5008.

Authors:  Hang Wu; Shuang Qu; Chenyang Lu; Huajun Zheng; Xiufen Zhou; Linquan Bai; Zixin Deng
Journal:  BMC Genomics       Date:  2012-07-24       Impact factor: 3.969

9.  Mechanistic insights into validoxylamine A 7'-phosphate synthesis by VldE using the structure of the entire product complex.

Authors:  Michael C Cavalier; Young-Sun Yim; Shumpei Asamizu; David Neau; Khaled H Almabruk; Taifo Mahmud; Yong-Hwan Lee
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.